As featured in Nutrition Industry Executive
A recent feature from Nutrition Industry Executive highlights the accelerating growth of the global men’s health supplement market—driven by preventative wellness, demand for transparency, and science-backed natural ingredients.
Valued at over $75 billion and projected to grow more than 10% annually through 2030, the category is being reshaped by men who are proactively managing vitality, performance, and aging. Today’s consumer is looking for clinically validated solutions to support everything from hormonal balance to cognitive function and urinary health.
Among the featured innovations is USPlus®, Valensa’s USP-verified saw palmetto extract, noted for its clinical efficacy in supporting lower urinary tract symptoms (LUTS)—a growing concern even among younger men with metabolic health issues.
Valensa CEO Umasudhan Palaniswamy joins industry leaders in outlining how natural solutions are meeting modern demands with credibility and results.